| 09.02.2022 |
Trajectories of depression, anxiety and stress among adults during the COVID-19 pandemic in Southern Switzerland: The Corona Immunitas cohort study |
Corona Immunitas Ticino |
Mehr |
| 11.06.2020 |
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study |
SEROCoV-POP |
Mehr |
| 18.10.2020 |
Variation in SARS-CoV-2 seroprevalence in school-children across districts, schools and classes |
Ciao Corona |
Mehr |
| 24.10.2020 |
Corona Immunitas: study protocol of a nationwide program of SARS-CoV-2 seroprevalence and seroepidemiologic studies in Switzerland |
Corona Immunitas |
Mehr |
| 16.11.2020 |
Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among Hospital Workers - a multicentre cross-sectional study |
Corona Immunitas |
Mehr |
| 30.11.2020 |
Prevalence of SARS-CoV-2 in household members and other close contacts of COVID-19 cases: a serologic study in canton of Vaud, Switzerland |
Unisanté Lausanne |
Mehr |
| 07.12.2020 |
Corona Immunitas Fribourg Immunité de la population Episode 1/2020 |
Corona Immunitas Fribourg |
Mehr |
| 19.10.2021 |
Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study |
SEROCoV-POP |
Mehr |
| 01.02.2021 |
Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak |
SEROCoV-POP |
Mehr |
| 17.11.2020 |
Perceptions of immunity and vaccination certificates among the general population: a nested study within a serosurvey of anti-SARS-CoV-2 antibodies (SEROCoV-POP) |
SEROCoV-POP |
Mehr |
| 14.07.2020 |
Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland |
SEROCoV-POP |
Mehr |
| 02.03.2021 |
Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools |
Ciao Corona |
Mehr |
| 04.02.2021 |
Depressive Symptoms in Swiss University Students during the COVID-19 Pandemic and Their Correlates |
Corona Immunitas Winterthur |
Mehr |
| 26.03.2021 |
Prevalence of SARS-CoV-2 in household members and other close contacts of COVID-19 cases: a serologic study in canton of Vaud, Switzerland |
SérocoViD |
Mehr |
| 19.04.2021 |
Corona Immunitas Fribourg Immunité de la population Episode 2/2021 |
Corona Immunitas Fribourg |
Mehr |
| 12.07.2021 |
Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study |
Corona Immunitas Zurich |
Mehr |
| 15.07.2021 |
Long-term Symptoms After SARS-CoV-2 Infection in Children and Adolescents |
Ciao Corona |
Mehr |
| 03.08.2021 |
A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma |
Corona Immunitas |
Mehr |
| 01.06.2021 |
Corona Immunitas Neuchâtel Immunité de la population - Phase 2 et 3 |
Corona Immunitas Neuchâtel |
Mehr |
| 08.10.2020 |
Prevalence of SARS-CoV-2 antibodies among Swiss hospital workers: Results of a prospective cohort study |
SURPRISE |
Mehr |
| 14.10.2021 |
Impact of baseline SARS-CoV-2 antibody status on syndromic surveillance and the risk of subsequent COVID-19—a prospective multicenter cohort study |
SURPRISE |
Mehr |
| 18.05.2021 |
Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among hospital workers – A multicentre cross-sectional study |
SURPRISE |
Mehr |
| 01.06.2021 |
SARS-CoV-2 antibodies among employees – Report 2 |
Corona Immunitas Nestlé |
Mehr |
| 08.11.2021 |
Corona Immunitas Fribourg Immunité de la population Episode 3/2020 |
Corona Immunitas Fribourg |
Mehr |
| 01.11.2021 |
SARS-CoV-2 antibodies among employees – Report 1 |
Corona Immunitas Nestlé |
Mehr |
| 01.07.2021 |
COVID-19: Port du masque dans le canton de Fribourg |
Corona Immunitas Fribourg |
Mehr |
| 19.10.2021 |
Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study |
SPECCHIO-COVID 19 |
Mehr |
| 07.07.2021 |
Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance |
SPECCHIO-COVID 19 |
Mehr |
| 31.01.2022 |
Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland |
SPECCHIO-COVID 19 |
Mehr |
| 15.06.2021 |
Insights into household transmission of SARS-CoV-2 from a population-based serological survey |
SPECCHIO-COVID 19 |
Mehr |
| 01.03.2022 |
Forgoing healthcare during the COVID-19 pandemic in Geneva, Switzerland – A cross-sectional population-based study |
SPECCHIO-COVID 19 |
Mehr |
| 22.11.2021 |
Perceptions of vaccination certificates among the general population in Geneva, Switzerland |
SPECCHIO-COVID 19 |
Mehr |
| 14.12.2021 |
COVID-19 vaccination acceptance in the canton of Geneva: a cross-sectional population-based study |
SPECCHIO-COVID 19 |
Mehr |
| 01.03.2022 |
Risk of reinfection after seroconversion to SARS-CoV-2: A population-based propensity-score matched cohort study |
SPECCHIO-COVID 19 |
Mehr |
| 26.10.2021 |
Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021 |
SPECCHIO-COVID 19 |
Mehr |
| 12.01.2022 |
High SARS-CoV-2 seroprevalence but no severe course of COVID-19 disease among people on opioid agonist treatment in Zurich: a cross-sectional study |
Corona Immunitas Zürich |
Mehr |
| 28.02.2022 |
The Corona Immunitas Digital Follow-Up eCohort to Monitor Impacts of the SARS-CoV-2 Pandemic in Switzerland: Study Protocol and First Results |
Corona Immunitas |
Mehr |
| 10.03.2022 |
Prévalence d’anticorps contre le coronavirus SARS-CoV2 dans la population en Valais |
Corona Immunitas Valais |
Mehr |
| 16.03.2022 |
Seroprevalence of SARS-CoV-2 antibodies, associated factors, experiences and attitudes of nursing home and home healthcare employees in Switzerland |
Corona Immunitas Zurich |
Mehr |
| 16.03.2022 |
Mental health of individuals infected with SARS-CoV-2 during mandated isolation and compliance with recommendations—A population-based cohort study |
Corona Immunitas Zurich |
Mehr |
| 28.01.2022 |
Symptoms compatible with long-COVID in healthcare workers with and without SARS-CoV-2 infection – results of a prospective multicenter cohort. |
SURPRISE |
Mehr |
| 05.02.2022 |
Impact of respirator versus surgical masks on SARS-CoV-2 acquisition in healthcare workers: a prospective multicentre cohort. |
SURPRISE |
Mehr |
| 18.01.2021 |
Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 Antibodies |
SURPRISE |
Mehr |
| 22.11.2021 |
Digital SARS-CoV-2 Detection Among Hospital Employees: Participatory Surveillance Study |
SURPRISE |
Mehr |
| 17.12.2021 |
No neutralizing effect of pre-existing tick-borne encephalitis virus antibodies against severe acute respiratory syndrome coronavirus-2: a prospective healthcare worker study |
SURPRISE |
Mehr |
| 23.03.2022 |
Why Vaccinate Against COVID-19? A Population-Based Survey in Switzerland |
Corona Immunitas Ticino |
Mehr |
| 01.06.2022 |
The impact of screen time and green time on mental health in children and adolescents during the COVID-19 pandemic |
Corona Immunitas Ticino |
Mehr |
| 20.06.2022 |
Is living in a household with children associated with SARS-CoV-2 seropositivity in adults? Results from the Swiss national seroprevalence study Corona Immunitas |
Corona Immunitas St. Gallen |
Mehr |
| 04.08.2022 |
Functional immunity against SARS-CoV-2 in the general population after a booster campaign and the Delta and Omicron waves, Switzerland, March 2022 |
Corona Immunitas |
Mehr |
| 04.08.2022 |
Functional immunity against SARS-CoV-2 in the general population after a booster campaign and the Delta and Omicron waves, Switzerland, March 2022 |
Corona Immunitas |
Mehr |
| 25.08.2022 |
Adherence to Coronavirus Disease 2019 Preventive Measures in a Representative Sample of the Population of the Canton of Vaud, Switzerland |
Corona Immunitas Vaud |
Mehr |
| 08.09.2022 |
Lifestyle Behaviours of Children and Adolescents During the First Two Waves of the COVID-19 Pandemic in Switzerland and Their Relation to Well-Being: An Observational Study |
Corona Immunitas |
Mehr |
| 16.09.2022 |
SARS-CoV-2 infection among employees working from home and on site: An occupational study in Switzerland |
Corona Immunitas Nestlé |
Mehr |
| 17.10.2022 |
Development of hybrid immunity during a period of high incidence of infections with Omicron subvariants: A prospective population based multi-region cohort study |
Corona Immunitas |
Mehr |
| 10.01.2023 |
Associations between Depression and Self-Reported COVID-19 Symptoms among Adults: Results from Two Population-Based Seroprevalence Studies in Switzerland |
Corona Immunitas Ticino |
Mehr |
| 25.01.2023 |
The Protective Role of Social-Oriented Digital Media Use in Children’s and Adolescents’ Life Satisfaction During the Covid-19 Pandemic: A Latent Growth Curve Model |
Corona Immunitas Ticino |
Mehr |
| 04.03.2023 |
Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study |
Corona Immunitas Fribourg |
Mehr |
| 23.03.2023 |
Changes in socioeconomic resources and mental health after the second COVID-19 wave (2020-2021): a longitudinal study in Switzerland |
Corona Immunitas Fribourg |
Mehr |
| 31.05.2023 |
Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study |
Corona Immunitas Zurich |
Mehr |
| 22.06.2023 |
Post COVID-19 condition, work ability and occupational changes in a population-based cohort |
Corona Immunitas Zurich |
Mehr |
| 18.08.2022 |
Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort |
Corona Immunitas Zurich |
Mehr |
| 24.04.2023 |
Adverse effects, perceptions and attitudes related to BNT162b2, mRNA-1273 or JNJ-78436735 SARS-CoV-2 vaccines: Population-based cohort |
Corona Immunitas Zurich |
Mehr |
| 12.12.2021 |
Individual-Level Evaluation of the Exposure Notification Cascade in the SwissCovid Digital Proximity Tracing App: Observational Study |
Corona Immunitas Zurich |
Mehr |
| 16.08.2021 |
Adherence and Association of Digital Proximity Tracing App Notifications With Earlier Time to Quarantine: Results From the Zurich SARS-CoV-2 Cohort Study |
Corona Immunitas Zurich |
Mehr |
